MATCHING-ADJUSTED INDIRECT COMPARISONOF UPADACITINIB VERSUS VEDOLIZUMAB AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Walter Reinisch  1     Severine Vermeire  2     Charlotte Hedin  3     David T. Rubin  4     Julian PanĂ©s  5     Huiwen Deng  6     Si Xuan  6     Lani Wegrzyn  6     John Liu  6     Dapo Ilo  6     Wen Zhou  6     Yuri Sanchez Gonzalez  6     Remo Panaccione  7    
1 Medical University of Vienna, Wien, Austria
2 University Hospital Leuven, Leuven, Belgium
3 Karolinska Institutet, Stockholm, Sweden
4 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
5 Hospital Clinic Barcelona, Barcelona, Spain
6 AbbVie Inc., North Chicago, United States
7 University of Calgary, Calgary, Canada

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing